U.S. Leisure Stock News

Arrowhead Pharmaceuticals (ARWR) is back in focus after two late stage RNA interference programs hit important milestones. Plozasiran delivered positive Phase 3 topline data in severe hypertriglyceridemia, and zodasiran’s Phase 3 YOSEMITE trial has now completed enrollment. See our latest analysis for Arrowhead Pharmaceuticals. The recent late stage cardiometabolic data appear to be feeding into Arrowhead Pharmaceuticals’ share price momentum, with a 30 day share price return of 7.11% and a...

CubeSmart (CUBE) has reaffirmed its income return profile, with the Board of Trustees declaring a quarterly dividend of $0.53 per common share for the period ending September 30, 2026. See our latest analysis for CubeSmart. The reaffirmed dividend sits alongside a steady pick up in CubeSmart's share price momentum, with a 7 day share price return of 3.19% and a year to date share price return of 19.86%, while the 1 year total shareholder return is 9.09%. If CubeSmart's steady income and price...

Big tech’s heavy spending on artificial intelligence is suddenly under the microscope after Meta shares dropped 11% on plans to lift annual spending to as much as US$145b, even as quarterly profit fell 14% to US$6b and free cash flow slid to a five year low of US$784 million. With Google also facing questions around the pay off from high AI budgets, many investors are rethinking which companies might benefit or struggle as this theme plays out. This article looks at three business...

Over the last 7 days, the United States market has experienced a 2.6% drop, yet it remains up by 14% over the past year with earnings forecasted to grow by 17% annually. In this environment, identifying undervalued stocks can be a strategic approach for investors seeking opportunities where current prices may not fully reflect future growth potential.

Over the last 7 days, the United States market has experienced a 2.6% drop, yet it remains up by 14% over the past year with earnings forecasted to grow by 17% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business and potential alignment of interests between management and shareholders.

Over the last 7 days, the U.S. market has dropped 2.6%, but it has risen by 14% over the past year, with earnings projected to grow annually by 17% in the coming years. In light of these conditions, investors may find value in penny stocks—an investment area that still holds relevance despite being an older term. By focusing on companies with solid financials and potential for growth, investors can uncover opportunities among smaller or less-established firms that might offer both stability...

In the second quarter of 2026, AMC Entertainment Holdings reported revenue of US$1,596.7 million, up from US$1,397.9 million a year earlier, while its net loss widened to US$11.4 million and basic loss per share from continuing operations moved to US$0.02. The company also highlighted the exceptional performance of “The Odyssey,” which delivered the strongest two-week IMAX run in history, underscoring how premium formats and sold-out high-end showtimes are becoming a critical driver of...

BWX Technologies has delivered a very strong run over the last five years, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiple checks currently point to the stock trading at a premium to those fundamentals. BWX Technologies has returned 215.2% over five years, which sets a high bar for any further upside to be supported by fundamentals. The company’s valuation can be supported by expectations for continued cash flow generation from its core defense and...

United Therapeutics (UTHR) stock is in focus after the company reported statistically significant phase 3 ADVANCE OUTCOMES results for its investigational PAH therapy ralinepag, with full data recently published in The Lancet. See our latest analysis for United Therapeutics. The latest ralinepag data and board appointment of Dr. Victor Dzau come as United Therapeutics trades at US$524.70, with the share price return up 5.63% year to date but the 90-day share price return down 8.16%. Over a...

Chubb stock has delivered a strong 126.4% total return over the past 5 years, yet the current checks send a mixed message, with the Excess Returns intrinsic value estimate suggesting the shares trade at a sizeable discount while the broader valuation framework does not flag the stock as an obvious bargain. Over 5 years, Chubb has returned 126.4%, which puts recent share price strength at the center of any valuation discussion. Future expectations for underwriting quality and capital...

In July 2026, Harley-Davidson, Inc. reported that second-quarter net income fell to US$79.81 million from US$107.57 million a year earlier, with first-half net income dropping to US$104.58 million from US$240.67 million, while continuing to execute its share repurchase program. Despite the weaker earnings, Harley-Davidson has completed repurchases totaling 24,470,194 shares for about US$1.33 billion since July 2024, signaling ongoing capital returns even as profitability softens. Next, we’ll...

Omnicom Group walked into this earnings print with the stock quietly grinding higher in recent weeks. Today that calm broke. Shares were down about 4% intraday after the release, even as the core advertising and marketing engine delivered a sharp earnings punch. The headline this quarter is profit power, not top line drama. Non GAAP adjusted earnings per share landed at US$2.65, and core adjusted EBITA margin sat near 17.8%. That is the story the market is wrestling with: a lower share price...

Old National Bancorp recently reported second-quarter 2026 results, with net interest income of US$578.99 million, net income of US$253.41 million, diluted EPS of US$0.65, net charge-offs of US$32.2 million, and completion of a buyback totaling 5,148,549 shares for US$123.5 million. This combination of higher earnings, stable credit costs, and active capital return gives investors fresh information on the bank’s current profitability and balance sheet management. We’ll now assess how this...

In recent weeks, Bitmine Immersion Technologies accelerated its Ethereum accumulation to nearly 5% of circulating supply and stepped up a US$4.00 billion share repurchase program, while its chairman publicly emphasized Ethereum’s growing role in digital asset infrastructure and policy debates. This combination of aggressive treasury activity and vocal advocacy has positioned Bitmine as a high-profile proxy for institutional interest in Ethereum’s broader ecosystem. We’ll now examine how...

Columbia Banking System (COLB) drew fresh attention on July 23, 2026, after reporting second quarter earnings, updated net charge-offs of $30 million, and progress on a multi-hundred-million-dollar share repurchase. See our latest analysis for Columbia Banking System. At a share price of $30.78, Columbia Banking System has seen short term share price pressure, with a 7 day share price return down 5.67%, while the year to date share price return of 9.19% and 1 year total shareholder return of...

Patrick Industries, Inc. has reported past second-quarter 2026 results showing sales of US$1,041.7 million, with net income rising to US$43.42 million and diluted earnings per share from continuing operations increasing to US$1.28 compared with the prior year. Despite slightly lower year-to-date sales versus the same period last year, Patrick Industries delivered higher profitability and earnings per share, underscoring the impact of margin improvement and cost discipline on its overall...

After a near doubling in the last year, Veeco Instruments now sits in a zone where recent gains and the latest valuation checks are no longer pointing to an obvious bargain, even though the share price has pulled back sharply in the past month. Veeco Instruments has returned 97.7% over the past year, which puts the recent selloff into context and raises the question of how much of the good news may already be reflected in the price. Future expectations for revenue growth and cash generation...

In the second quarter of 2026, QuantumScape Corporation reported a net loss of US$98.24 million and basic loss per share of US$0.16, both lower than the same period in 2025. Over the first half of 2026, QuantumScape cut its cumulative net loss to US$199.04 million and loss per share to US$0.32, highlighting a slower cash burn as it continues to fund solid-state battery development. Next, we will assess how this narrower quarterly net loss shapes QuantumScape’s investment narrative built...

Navios Maritime Partners has delivered very strong long term returns over the past five years, yet the current valuation checks still suggest the stock leans cheap rather than stretched. The stock has returned about 262.5% over 5 years. This puts a lot of focus on whether today’s price still offers a margin of safety. For a shipping partnership like Navios Maritime Partners, investor expectations around shipping rates and fleet utilisation can support the current valuation. At the same time,...

Talos Energy (TALO) is drawing attention ahead of its upcoming June 2026 quarter earnings report, with expectations for significant earnings growth and a positive Earnings ESP refocusing investor interest on the stock. See our latest analysis for Talos Energy. Talos Energy's share price has moved to $14.25 after a 1-day share price return of 4.24%, with the year to date share price return of 26.67% and 1-year total shareholder return of 61.20% pointing to building momentum despite some recent...

Renasant stock barely flinched after earnings, easing about 1% in Thursday trading, yet the results were anything but sleepy. The real story sits in profitability. Adjusted earnings per share for the quarter came in just under US$1, and net income held close to US$90 million, supported by a solid net interest margin and a tighter cost to income ratio than a year ago. Investors saw a quiet price move into these numbers and a much louder message in the income statement. The rest of the release...

Harrow recently presented three studies at the ASRS 2026 Annual Meeting highlighting interim clinical and real-world data for IHEEZO and BYOOVIZ in retinal care. The early IHEEZO data suggesting improved post-injection comfort without added antisepsis risk could meaningfully influence how ophthalmologists think about intravitreal procedures. We’ll now explore how encouraging interim IHEEZO pain and safety findings may influence Harrow’s investment narrative built around retina...

Four Corners Property Trust (FCPT) has combined an upsized credit facility with its largest acquisition to date, the Mission Pet Health portfolio, giving investors fresh information on both balance sheet structure and portfolio mix. See our latest analysis for Four Corners Property Trust. At a share price of $26.33, Four Corners Property Trust has recorded a 13.30% year to date share price return. The 1 year total shareholder return of 8.91% sits alongside multi year total shareholder returns...

Global markets are wrestling with mixed inflation signals, shifting rate expectations and higher energy costs. That backdrop keeps investors focused on assets that can potentially benefit as digital infrastructure and new transaction systems evolve. The Top Cryptocurrency and Blockchain Stocks screener filters this wide universe into a more manageable starting list based on clear, transparent criteria. That helps you focus on businesses linked to crypto and blockchain themes without having to...